Comparision of the Characteristics of Familial and Sporadic Cases in Patients with Gastric Cancer
نویسندگان
چکیده
In this study, it was aimed to find the percentage of the non-familial and familial cases and comparison of their characteristic susing 2004 Canadian criteria in our cancer patients. The data from the files of 200 patients with histopathologically proven gastric cancer registered in our Medical Oncology Clinic were evaluated between January 2001 and December 2005. In our study, the ratio of familial cases is 10%. The mean ages of the patients are 56.44±0.78 in non-familial group and 53.30±2.90 in familial group. There were 113 males (62.77%), 67 females (37.23%) in non-familial group and 14 males (70%), 6 females (30%) in familial group. Histological types in familial and non-familial groups are; intestinal type 23.8% (n:3) and 75.23% (n:82); diffuse type 76.92% (n:10) and 24.77% (n:27) (p<0.01), respectively. The rate of cancers in localized stages are 5% (n:1) and 26,67% (n:48); where as the rates of advanced-stage cancers were 95% (n:19) and 73.33% (n:132) (p<0.01) in familial and non-familial groups respectively. Non-familial patients were 9.38% (n:12) Hp negative and 90.62% (n:116) were Hp positive where as familial cases were 100% (n:13) Hp positive (p<0.01). Blood groups in familial and non-familial groups are; Group A were 33.33% (n=2) and 58.46% (n:38); group B were 16.67% (n:1) and 10.77% (n:7), group O were 50% (n:3) and 29.23% (n:19) respectively. One patient (1.54%) in non-familial group was AB positive. Endoscopic screening should strongly be suggested in cases of unexplained upper abdominal complaints, especially for those people living in rural area in Van region.
منابع مشابه
Prophylactic gastrectomy in familial gastric cancer: case report and review of literature
Absract Gastric cancer is the fourth most common cancer and the second leading cause of cancer death. Most cases are sporadic and only 10% of patients, show familial clustering. Among these patients, 1 to 3 % have hereditary diffuse gastric cancer (HDGC), which is autosomal-dominant and present in younger ages. Mutations in Ecadherin gene CDH1 has been identified in 30 to 50% of patient...
متن کاملشاخص های اپیدمیولوژیک و کلینیکو پاتولوژیک سرطانهای کولورکتال در ساری 1386-1378
Background and Purpose: Each year, about 50,000 new cases of cancer occur in Iran and the most common being the gastrointestinal (GI) tract (38%). Colorectal cancers account for the 3rd and 4th most prevalent cancers in Iranian men and women, respectively. Since genetic and environmental factors lead to differences in colorectal cancer occurrence in different geographic regions and races, we ...
متن کاملTHE MUTATIONS OF RET PROTO-ONCOGENE IN MEDULLARY THYROID CARCINOMAS IN IRAN
MeduIIary thyroid carcinoma (MTC) occurs both sporadically and in the autosomal dominantly inherited multiple endocrine neoplasia (MEN) type 2 syndromes. The distinction between true sporadic MTC and a new mutation familial case is important for future clinical management of both the patient and family. The susceptibility gene for hereditary MTC is the RET proto-oncogene. DNA analysis for g...
متن کاملبررسی ارتباط سرطان های کولورکتال با سابقه فامیلی سرطان های دستگاه گوارش و سابقه فردی پولیپ های روده بزرگ در شهر خرم آباد در سال1391
Background: The aim of this study was to investigate the relationship of familial history of gastrointestinal cancers and personal history of colon polyps with colorectal cancer incidence in khorramabad in 2012. Materials and Methods: This cross-sectional study included 50 patients with definite diagnosis of colon cancer based on colonoscopy and pathology in 2012. The control group included 56 ...
متن کاملبررسی چند شکلی جایگاه C>A 938 – پروموتر 2P ژن bcl2 در افراد مبتلا به سرطان معده
Background and purpose: Gastric cancer is the fourth most common cancer and the second leading cause of cancer death worldwide. North of Iran is a high risk area for gastric cancer. Bcl2 family is the most important regulator of apoptosis and -938C>A single nucleotide polymorphism of bcl2 gene promoter has been demonstrated to influence gastric cancer susceptibility. In this research we studied...
متن کامل